Resveratrol: what the evidence actually shows
Supplement (polyphenol)
Resveratrol is what a longevity hype cycle looks like after 20 years: more than 21,000 indexed papers and roughly 9,700 human records, yet no convincing human benefit at supplement doses. The famous sirtuin-activation story weakened under replication attempts, a major industry programme was abandoned, and human trials keep returning null or marginal results — partly because oral bioavailability is extremely poor.
PubMed footprint (2026-08-29): 21,601 indexed publications, 9,689 involving humans (search: resveratrol).
What it is
Resveratrol is a polyphenol from grape skin and Japanese knotweed that shot to fame in the 2000s as the proposed explanation for the “French paradox” and as a sirtuin activator that extended lifespan in some model organisms.
What the research actually shows
Human trials across metabolic health, cardiovascular markers and inflammation have produced inconsistent, mostly small or null effects. The molecule is metabolised within minutes of ingestion, so plasma levels of the parent compound stay far below anything used in cell studies. The original sirtuin-activation biochemistry was later shown to depend partly on an assay artefact, and follow-up animal work found lifespan extension only in specific contexts such as high-fat diets.
Why it still matters
Resveratrol is the reference case for reading longevity headlines: spectacular mechanism press coverage, billions in market value, and two decades later no demonstrated human aging outcome. Any new molecule marketed on cell-culture sirtuin data should be weighed against this precedent.
FAQ
Does resveratrol extend human lifespan?
There is no evidence it does. Human trials show inconsistent, mostly marginal effects on intermediate markers.
Why did resveratrol work in the lab but not in people?
Very poor oral bioavailability, dose gaps of orders of magnitude, and mechanism findings that partly rested on assay artefacts.
Is resveratrol dangerous?
At common supplement doses it is generally well tolerated; high doses have caused gastrointestinal upset in trials.
Sources & further reading
→ Evaluating a clinic that sells this? Build a provider question list
Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.